Our client is a pre-clinical biotech company determined to combat late-stage cancers, neurodegenerative diseases and neuropathic pain. They have engineered an intracellular drug delivery technology that uses pore-forming proteins for intracellular targets.

Their technology binds to a specific cell surface receptor, undergoes endocytosis and forms a translocation channel in the endosomal membrane, delivering up to 80% therapeutic cargo into the cytosol, compared to less than 1% delivered by Lipid NanoParticles. They have 2 lead assets ready to start clinical development, and a pipeline of pre-clinical assets.

The current team consists of experienced leaders with a proven track record in pharma drug development including project management, target discovery, lead identification, optimization and clinical development. Additionally, they work with a strong strategic network alliance of collaborators, experts, partners, associates and counsellors. They now seek a Chairperson to join their team.

The Chairperson will lead, chair and oversee the performance of the leadership team, supporting the CEO to nurture and facilitate the culture necessary to bring sustainable success to the company. They will be required to establish and support the company’s series A fundraising of up to £10M and help identify and support Pharma partners for co-development of lead assets and out-licensing of delivery technology.

The role holder will have previous experience as a Chair and ideally bring expertise in drug development, Pharma interactions, and fundraising. It would be advantageous to have an understanding of clinical development and IP licensing. 

The role requires 2 days per month and will be remunerated.